Discussion in 'Other Health News and Research' started by MeSci, Feb 7, 2014.
I couldn't find a thread on this, which was in NEJM 22nd January.
If medical research is to be improved then open data is necessary. The debate is really about how to do this. I think that researchers should indeed have exclusive right to data for a period of time, but the debate is really on how long that should be. Immediate release might be too soon, several years later is definitely too late.
If the PACE trial had public data release after one year, then we would now have possibly disproven their findings. So I wonder how much that kind of research will agree with open data? I also wonder what they mean by open data. Its not a drug trial, they might argue that for some reason they should be exempt. They might also have half-way open data, in which the public has no access but only certain groups.
You can also try a Google Site Search
Separate names with a comma.